Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 17 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
AVANU from Aalst, company number BE0871421670, closed financial year 2025 with a result of € 4,588 after tax. For that financial year AVANU recorded a gross margin of € 11,161 and equity of € 100,176. Compared with financial year 2024, the result moved from € 10,273 to € 4,588. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 100,176
▲ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4,588
▼ 55% vs 2024
Profit after tax over the fiscal year.
€ 55,034
▲ 8% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -24,824.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 22,115
▲ 20% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 850
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 21,639 | € 20,710 | € 16,670 | € 11,161 | ▼ 33% |
| Profit after taxes | € 12,647 | € 12,750 | € 10,273 | € 4,588 | ▼ 55% |
| Equity | € 72,566 | € 85,315 | € 95,589 | € 100,176 | ▲ 5% |
| Total debts | € 457,443 | € 453,142 | € 446,134 | € 444,240 | |
| Cash | € 60,270 | € 66,971 | € 50,828 | € 55,034 | ▲ 8% |
| Land & buildings | - | - | € 24,897 | € 22,382 | ▼ 10% |
| Retained profit | € -52,434 | € -39,685 | € -29,411 | € -24,824 | ▲ € 4,588 |
| Balance sheet total | € 530,009 | € 538,457 | € 541,723 | € 544,416 |
By gross margin, AVANU ranks 14th of 17 companies with main activity “Detailhandel in farmaceutische producten” in Aalst that publish figures (fiscal year 2025).
Key figures of AVANU, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about AVANU the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to AVANU?
What happened at AVANU in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 4,588 (▼ 55% vs 2024). filed late Source: NBB ↗
- New establishment in Aalst. KBO
- Start of the company according to the CBE. KBO
In short
From € 12,647 profit in 2022 to € 4,588 profit in 2025.
Paid € 13,730 in corporate taxes since 2022.
Best year ever: 2023, with € 12,750 profit.
Management
Behind AVANU are Herman Annaert, Koreno BV and Machteld Van Nuffel. It owns 100% of Koreno itself.
Establishments
Establishment units
Physical locations of this company
Werf 4
9300 Aalst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Aalst
Same main activity (Detailhandel in farmaceutische producten), 18 active companies in Aalst, largest first.
€ 289,996 gross margin · 2025
€ 171,509 gross margin · 2025
€ 170,570 gross margin · 2025
€ 170,258 gross margin · 2025
€ 153,744 gross margin · 2025
€ 144,920 gross margin · 2025
Details
- Company number
- 0871.421.670
- VAT number
- BE 0871.421.670
- Registered office
- Werf 4, 9300 Aalst
- Names & denominations
- AVANU
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 January 2005
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers